RU97120998A - FUMARATE (R) - (METHYLAMINOSULFONYLMETHYL) -3- (N-METHYLPYRROLIDIN-2-YLMETHYL) -1H-INDOLA, METHOD FOR ITS PREPARATION, MEANS FOR TREATING MIGRAINE, PHARMACEUTICAL LENGIS - Google Patents

FUMARATE (R) - (METHYLAMINOSULFONYLMETHYL) -3- (N-METHYLPYRROLIDIN-2-YLMETHYL) -1H-INDOLA, METHOD FOR ITS PREPARATION, MEANS FOR TREATING MIGRAINE, PHARMACEUTICAL LENGIS

Info

Publication number
RU97120998A
RU97120998A RU97120998/04A RU97120998A RU97120998A RU 97120998 A RU97120998 A RU 97120998A RU 97120998/04 A RU97120998/04 A RU 97120998/04A RU 97120998 A RU97120998 A RU 97120998A RU 97120998 A RU97120998 A RU 97120998A
Authority
RU
Russia
Prior art keywords
fumarate
methylaminosulfonylmethyl
ylmethyl
methylpyrrolidin
treating migraine
Prior art date
Application number
RU97120998/04A
Other languages
Russian (ru)
Other versions
RU2161618C2 (en
Inventor
Джеймс Уитес Мартин
Original Assignee
Пфайзер Рисерч Энд Дивелопмент Компани, Н.В./С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9510223.2A external-priority patent/GB9510223D0/en
Application filed by Пфайзер Рисерч Энд Дивелопмент Компани, Н.В./С.А. filed Critical Пфайзер Рисерч Энд Дивелопмент Компани, Н.В./С.А.
Publication of RU97120998A publication Critical patent/RU97120998A/en
Application granted granted Critical
Publication of RU2161618C2 publication Critical patent/RU2161618C2/en

Links

Claims (6)

1. Фумарат (R)-5-(метиламиносульфонилметил)-3-(N-метил-пирролидин-2-илметил)-IH-индола.1. Fumarate of (R) -5- (methylaminosulfonylmethyl) -3- (N-methyl-pyrrolidin-2-ylmethyl) -IH-indole. 2. Фармацевтическая композиция для лечения мигрени, включающая активный агент и фармацевтически приемлемый разбавитель или носитель, отличающаяся тем, что она содержит эффективное количество фумарата по п .1 в качестве активного агента. 2. A pharmaceutical composition for the treatment of migraine comprising an active agent and a pharmaceutically acceptable diluent or carrier, characterized in that it contains an effective amount of fumarate according to claim 1 as an active agent. 3. Фумарат по п.1 в качестве средства для лечения мигрени. 3. Fumarate according to claim 1 as a means for treating migraine. 4. Способ получения фумарата (R)-5-(метиламиносульфонилметил)-3-(N-метилпирролидин-2-илметил)-IH-индола, включающий взаимодействие (R)-5-(метил-аминосульфонилметил)-3-(N-метилпирролидин-2-илметил)-1H-индола с фумаровой кислотой. 4. A method of producing a (R) -5- (methylaminosulfonylmethyl) -3- (N-methylpyrrolidin-2-ylmethyl) -IH-indole fumarate, comprising the reaction of (R) -5- (methylaminosulfonylmethyl) -3- (N- methylpyrrolidin-2-ylmethyl) -1H-indole with fumaric acid. 5. Способ по п. 4, отличающийся тем, что фумаровую кислоту используют в количестве 1 эквивалента. 5. The method according to p. 4, characterized in that fumaric acid is used in an amount of 1 equivalent. 6. Способ лечения мигрени у человека, включающий введение эффективного количества фумарата или фармацевтической композиции, соответственно, по п.1 или 2. 6. A method of treating migraine in humans, comprising administering an effective amount of a fumarate or pharmaceutical composition, respectively, according to claim 1 or 2.
RU97120998/04A 1995-05-20 1996-04-10 (r)-(methylaminosulfonylmethyl)-3-(n-methylpyrrolidine-2-yl- -methyl)-1h-indole fumarate, method of its preparing, agent for treatment of mirgaine, pharmaceutical composition for migraine treatment RU2161618C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent
GB9510223.2 1995-05-20

Publications (2)

Publication Number Publication Date
RU97120998A true RU97120998A (en) 1999-08-27
RU2161618C2 RU2161618C2 (en) 2001-01-10

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97120998/04A RU2161618C2 (en) 1995-05-20 1996-04-10 (r)-(methylaminosulfonylmethyl)-3-(n-methylpyrrolidine-2-yl- -methyl)-1h-indole fumarate, method of its preparing, agent for treatment of mirgaine, pharmaceutical composition for migraine treatment

Country Status (42)

Country Link
US (1) US5994387A (en)
EP (1) EP0827503B1 (en)
JP (1) JP3233940B2 (en)
KR (1) KR100295255B1 (en)
CN (1) CN1063175C (en)
AP (1) AP738A (en)
AR (1) AR003949A1 (en)
AT (1) ATE194986T1 (en)
AU (1) AU701154B2 (en)
BG (1) BG63046B1 (en)
BR (1) BR9610858A (en)
CA (1) CA2219631C (en)
CO (1) CO5040221A1 (en)
CZ (1) CZ287939B6 (en)
DE (1) DE69609504T2 (en)
DK (1) DK0827503T3 (en)
DZ (1) DZ2034A1 (en)
ES (1) ES2148753T3 (en)
GB (1) GB9510223D0 (en)
GR (1) GR3034290T3 (en)
HK (1) HK1017884A1 (en)
HR (1) HRP960223B1 (en)
HU (1) HU217657B (en)
IL (1) IL118239A (en)
IS (1) IS1908B (en)
LV (1) LV11992B (en)
MA (1) MA23876A1 (en)
MX (1) MX9708966A (en)
MY (1) MY132066A (en)
NO (1) NO312068B1 (en)
NZ (1) NZ306448A (en)
OA (1) OA10747A (en)
PL (1) PL183142B1 (en)
PT (1) PT827503E (en)
RU (1) RU2161618C2 (en)
SK (1) SK281782B6 (en)
TN (1) TNSN96074A1 (en)
TR (1) TR199701397T1 (en)
UA (1) UA44320C2 (en)
WO (1) WO1996036632A1 (en)
YU (1) YU29496A (en)
ZA (1) ZA963938B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
WO2014012859A1 (en) * 2012-07-19 2014-01-23 Boehringer Ingelheim International Gmbh Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as medicament and the preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (en) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
EP0592438B1 (en) * 1990-10-15 1997-08-27 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Similar Documents

Publication Publication Date Title
HUT51136A (en) Process for producing pharmaceutical compositions for treating schisophreny, containing l-deprenil as active component
DE19875011I2 (en) Use of sertindole for the treatment of schiz ophrenia.
RU93053493A (en) SULPHATE SALT (2: 1) -3- [2- (DIMETHYLAMINO) ETHYL] -N-METHYL-1N-INDOL-5-METHESULPHONAMIDE AND INCLUSTERS CENTURIES CURRENT CHAIRS CURRENT CHAPTER , METHOD OF TREATING HEADACHE
RU94042466A (en) Pharmaceutically active bicyclic heterocyclic amines
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
KR970704429A (en) USE OF DROLOXIFENE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
IL115920A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
GB9418912D0 (en) Pharmaceutically active compounds
DE69800859D1 (en) Use of moxonidine to treat neuropathic pain
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
CA2216810A1 (en) Method for treatment of benign prostatic hypertrophy
RU97120998A (en) FUMARATE (R) - (METHYLAMINOSULFONYLMETHYL) -3- (N-METHYLPYRROLIDIN-2-YLMETHYL) -1H-INDOLA, METHOD FOR ITS PREPARATION, MEANS FOR TREATING MIGRAINE, PHARMACEUTICAL LENGIS
RU97104483A (en) SUITABLE ACID SALT 4- [2-AMINO-6- (CYCLOPROPYLAMINO) -9H-PURIN-9-IL] -2- CYCLOPENTEN-1-METHANOL AS ANTI-VIRUS AGENT
RU94040886A (en) Use of melatonine derivatives for sleep disturbance treatment, pharmaceutical composition
PL320342A1 (en) Thrombin inhibitor containing infusion solution, stable during storage
ATE216891T1 (en) USE OF IMMUNOSUPPRESSANTS TO TREAT SCHIZOPHRENIA
DE69103773D1 (en) DERIVATIVES OF HYDROXAMIC ACID INHIBIT THE LIPOXYGENASE.
DE69729201T2 (en) SULFON FLUORIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
CO5040221A1 (en) PHUMARATE SALT OF (R) -5- (METHYLAMINOSULPHONYLMETHYL) -3- (N-METHYL-PILRROLIDIN-2-ILMETILE) -1H-INDOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND A PROCEDURE TO PREPARE DI-CHA SALT
WO1995005364A3 (en) Inhibitors of biogenic amine transporters
RU95102777A (en) Method of treatment of reperfuse myocardial damage and "deafening"
RU97112901A (en) THROMBOLYTIC PRODUCTS
CA2341891A1 (en) The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
NO964252L (en) The use of spiramycin for the treatment of gastrointestinal defects caused by H. pylori